The study reveals that ARK1 controls spindle formation during malaria parasite division. Blocking this protein disrupted ...

Scientists have identified a unique protein, ARK1, which is essential for the malaria parasite's survival and transmission, offering a promising new target for antimalaria drugs.

The first-ever treatment for malaria in young babies and infants has been approved. On Tuesday, Novartis announced it had received approval for the treatment, Coartem Baby (known as Riamet Baby in ...

Explore the latest breakthrough in malaria drugs targeting a unique protein essential for the parasite's survival and transmission.

Add Yahoo as a preferred source to see more of our stories on Google. Spread largely by mosquitos, Malaria causes a fever, headaches, confusion and muscle pains among other symptoms and can be fatal.

New research shows the malaria parasite could be developing resistance to the current front-line treatment for the disease — a drug that has saved millions of lives. An anti-malaria drug that has ...

At the turn of the millennium, a new class of drugs derived from ancient Chinese herbal medicine revolutionized malaria care. Artemisinin's, as they're called, are based on extracts from the sweet ...

NEW YORK (AP) — Researchers on Wednesday reported two promising new approaches to counteract malaria’s growing resistance to medication — one involving a new class of drugs. Switzerland-based Novartis ...

Researchers analyzed the genomes of hundreds of malaria parasites to determine which genetic variants are most likely to confer drug resistance. Researchers at University of California San Diego ...

Scientists find ARK1 protein vital for malaria parasite division; disabling it halts replication and transmission, offering a ...

NEW YORK (AP) — Researchers on Wednesday reported two promising new approaches to counteract malaria’s growing resistance to medication — one involving a new class of drugs. Switzerland-based Novartis ...